11 hrs ago
Efavirenz use not linked to neurocognitive impairment
Andrea Antinori, from the National Institute for Infectious Disease in Rome, presenting at AIDS 2014.
Sovaldi and Ribavirin Cure High Rates of Those With HIV & Hep C
Sovaldi and ribavirin cured between 84 percent and 91 percent of people coinfected with HIV and genotypes 1 through 4 of hepatitis C virus , aidsmap reports.
Protease inhibitor therapy doesn't reduce the risk of malaria for HIV-positive pregnant women
Antiretroviral therapy based on the protease inhibitor lopinavir/ritonavir does not reduce the risk of malaria among HIV-positive pregnant women, research published in the online edition of the Journal of Infectious Diseases shows.
Sustiva (Efavirenz) Linked to Doubled Risk of Suicidality
People with HIV starting treatment regimens containing Sustiva have a more than doubled risk of suicidal thoughts, attempts and completed attempts, when compared with those beginning Sustiva-free regimens, MedPage Today reports.
Many People With HIV Could Switch to Newer, Safer Regimens
A majority of people taking antiretrovirals to treat HIV could switch to newer regimens with improved side effect profiles, according to an analysis of Australians living with the virus, aidsmap reports.
Therapy with newer, safer antiretrovirals an option for the majority of HIV-positive patients
The majority of patients taking antiretroviral therapy that includes drugs associated with long-term side-effects may have the option of switching to a novel regimen that uses newer and safer anti-HIV drugs, according to Australian research published in PLOS One.
Medical News Today
Initial treatment with efavirenz-containing antiretroviral regimen...
Initial treatment for HIV infection with an efavirenz-containing antiretroviral regimen doubles a patient's risk for suicidal thoughts , attempts, or completion, according to an article being published in Annals of Internal Medicine .
Annals of Internal Medicine
Efavirenz and the Risk for Suicidal Behaviors
The full report is titled "Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed Suicide.
Annals of Internal Medicine
Association Between Efavirenz as Initial Therapy for HIV-1 Infection...
Katie R. Mollan, MS; Marlene Smurzynski, PhD; Joseph J. Eron, MD; Eric S. Daar, MD; Thomas B. Campbell, MD; Paul E. Sax, MD; Roy M. Gulick, MD; Lumine Na, MS; Lauren O'Keefe, BS; Kevin R. Robertson, PhD; and Camlin Tierney, PhD From Center for Biostatistics in AIDS Research, Harvard School of Public Health, Brigham and Women's Hospital, and Harvard ... (more)
Study says common HIV drug may boost suicide risk
A medication commonly used to treat HIV appears to double the risk that patients will develop suicidal thoughts or take their lives, new research contends.